NMXS (Net Medical Xpress Solutions) Marketable Securities: $0.00 Mil (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Net Medical Xpress Solutions Marketable Securities?

Net Medical Xpress Solutions NMXS +0.14% Marketable Securities is $0.00 Mil as of Jun. 2018.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Net Medical Xpress Solutions's Marketable Securities for the quarter that ended in Jun. 2018 was $0.00 Mil.

Net Medical Xpress Solutions  (OTCPK:NMXS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Net Medical Xpress Solutions Marketable Securities Related Terms

Net Medical Xpress Solutions Marketable Securities Historical Data

* Premium members only.

The historical data trend for Net Medical Xpress Solutions's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Net Medical Xpress Solutions Marketable Securities Chart

Net Medical Xpress Solutions Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.00 0.00 0.00 0.00

Net Medical Xpress Solutions Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Mar18 Jun18
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Net Medical Xpress Solutions Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Net Medical Xpress Solutions (NMXS) has a Marketable Securities of $0.00 Mil as of Jun. 2018. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Net Medical Xpress Solutions and its competitors.
Is Net Medical Xpress Solutions' Marketable Securities too high?
Net Medical Xpress Solutions' current Marketable Securities is $0.00 Mil.
How does Net Medical Xpress Solutions' Marketable Securities compare to TVMD and UCBB?
Net Medical Xpress Solutions' Marketable Securities of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Net Medical Xpress Solutions and its competitors. Net Medical Xpress Solutions's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Net Medical Xpress Solutions stock overvalued right now?
Net Medical Xpress Solutions (NMXS) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Net Medical Xpress Solutions (NMXS), the current Marketable Securities is $0.00 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Net Medical Xpress Solutions Business Description

Address 8206 Louisiana Boulevard NE, Suite A, Albuquerque, NM, USA, 87113
Net Medical Xpress Solutions Inc is engaged in providing solutions to the telemedicine industry which deliver medical laboratory services. It offers proprietary software that links electronic medical records while enabling state-of-the-art conferencing and communications. The company's mobile fleet of vans is utilized to provide sales support for its clinical research organization. It also offers call centers, proprietary hardware implementations, diagnostic and clinical services, and software research and development capabilities.